(Q37051022)

17 August 2017

1 reference

title

Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies (English)

1 reference

17 August 2017

0 references

J Bramson

4

0 references

author name string

D E Spaner

series ordinal

1

1 reference

17 August 2017

R Foley

series ordinal

2

1 reference

17 August 2017

J Galipeau

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

27

1 reference

17 August 2017

2

1 reference

17 August 2017

208-217

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210905

17 August 2017

0 references

cites work

Oncogenic resistance to growth-limiting conditions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Toll-like receptors mediate proliferation and survival of multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Exploiting tumour hypoxia in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Tregs and rethinking cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Molecular mechanisms of endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Molecular imaging of cancer with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Targeting G protein-coupled A2a adenosine receptors to engineer inflammation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: role of adenosine deaminase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Discovery of O-GlcNAc transferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

The hexosamine biosynthesis pathway negatively regulates IL-2 production by Jurkat T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Adenosine receptors as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Expression and function of Toll-like receptors in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Pregnancy alters glucose-6-phosphate dehydrogenase trafficking, cell metabolism, and oxidant release of maternal neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Nucleoside transporters: from scavengers to novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Fever, cancer incidence and spontaneous remissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

S-Adenosylhomocysteine hydrolase as a target for intracellular adenosine action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Development of TLR9 agonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Activation of anti-hepatitis C virus responses via Toll-like receptor 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

'TaiLoRing' the response of dendritic cells to pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Inflammation and multiple myeloma: the Toll connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Inhibiting hypoxia-inducible factor 1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

New insights into the regulation of TLR signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

VEGF as a mediator of tumor-associated immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Adenosine receptors and mammalian toll-like receptors: synergism in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

The prevention of febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Signaling in B cells via Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Inhibition of VEGF signaling pathways in multiple myeloma and other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

The mechanism of adenosine formation in cells. Cloning of cytosolic 5'-nucleotidase-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

TGF beta inhibition for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Coley's toxins in perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Adenosine induced apoptosis in BHK cells via P1 receptors and equilibrative nucleoside transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Toll-like receptors on regulatory T cells: expanding immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Differential effect of prostaglandins E1 and E2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

p53 and NF-kappaB crosstalk: IKKalpha tips the balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Lessons from Coley's Toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Epilepsy controlled by low-carb diet's effect on brain channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Safety of the intranasal toll-like receptor 4 agonist CRX-675 in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Mycobacterium bovis bacille Calmette Guerin infection of human neutrophils induces CXCL8 secretion by MyD88-dependent TLR2 and TLR4 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Pharmacokinetics of 852A, an imidazoquinoline Toll-like receptor 7-specific agonist, following intravenous, subcutaneous, and oral administrations in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

p53 is a suppressor of inflammatory response in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Evidence that cytosolic and ecto 5'-nucleotidases contribute equally to increased interstitial adenosine concentration during porcine myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

A novel vicious cycle in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

The roles of adoptive and active forms of immunotherapy in the cure of children suffering from acute lymphoid leukemia: a) underestimation of active immunotherapy benefit, b) its immunogenetic indications to select sensitive patients, hence prevent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Immunology taught by Darwin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210905

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210905

1 reference

17 August 2017

1 reference